Topical Diclofenac Gel for Bone Spur

Evidence for Efficacy

The American College of Rheumatology recommends topical diclofenac gel as a first-line treatment for bone spur pain, providing superior pain relief with significantly fewer systemic adverse events compared to oral NSAIDs or acetaminophen 1
Moderate-certainty evidence shows topical NSAIDs reduce pain by 1.08 cm on a 10-cm visual analog scale within 1-7 days compared to placebo, with an odds ratio of 6.39 (CI 3.48-11.75) for symptom relief in patients with musculoskeletal pain conditions 1, 2
High-certainty evidence demonstrates significantly greater treatment satisfaction (OR 5.20, CI 2.03-13.33) compared to placebo in patients with musculoskeletal pain conditions 1, 2
Two randomized controlled trials comparing topical diclofenac with placebo recorded significant benefit for pain relief in osteoarthritis, which shares similar inflammatory mechanisms with bone spur pain, with a significant reduction in pain intensity 3

The American Heart Association notes that topical diclofenac has a superior safety profile compared to oral NSAIDs while maintaining equivalent pain relief, with gastrointestinal adverse events occurring at rates similar to placebo with topical formulations 1, 2
Systemic absorption is significantly lower with topical formulations, reducing cardiovascular and renal risks in patients with pre-existing conditions 2

The recommended dosing regimen is to apply topical diclofenac gel 4g to the affected area four times daily, with use for short-term treatment (<14 days initially), though studies support safety up to 1 year if needed in patients with musculoskeletal pain conditions 1, 2

For patients ≥75 years, topical diclofenac is strongly preferred over oral NSAIDs due to substantially greater risk for cardiovascular, gastrointestinal, and renal adverse reactions with oral formulations, with a significant reduction in risk of adverse events 1, 4
Exercise particular caution in patients with renal insufficiency, heart failure or cardiovascular disease, history of peptic ulcer disease or GERD, and concurrent use of anticoagulants or antiplatelet agents, as these conditions may increase the risk of adverse events 2, 4

Topical diclofenac is superior to acetaminophen for functional improvement and provides equivalent pain relief to oral NSAIDs but with significantly fewer systemic adverse events in patients with musculoskeletal pain conditions 1
Acetaminophen alone did not show statistically significant improvement in symptomatic relief compared to placebo in moderate-certainty evidence, with a significant difference in pain intensity between topical diclofenac and acetaminophen 1
Avoid opioids entirely, as they provide similar pain relief to NSAIDs but cause significantly more side effects, with a significant increase in risk of adverse events 1, 2